Research Briefs
Date of this Version
6-4-2018
Abstract
Post-angioplasty, patient adherence to recommended antiplatelet therapy decreased when newer, more expensive drugs were introduced. From 2008-2016, as the use of newer agents increased, the proportion of patients not filling any antiplatelet prescription within 30 days of discharge increased from 6.4% to 19.1%. In the subsequent 12 months, the newer drugs were associated with higher patient costs and lower adherence to recommended therapy.
Document Type
Brief
Number
43
See Original Study
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2681655
License
This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 License.
Keywords
medication adherence, angioplasty, antiplatelet therapy, health disparities
View On LDI Website
Citation For This Study
Dayoub EJ, Seigerman M, Tuteja S, et al. Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among AntiplateletNaive Patients After Percutaneous Coronary Intervention, 2008-2016. JAMA Intern Med. Published online May 21, 2018. doi:10.1001/jamainternmed.2018.0783
Date Posted: 04 June 2018